Christopher James Vandenbussche, M.D., PH.D.
Cytopathology Physician · Baltimore, MD
Christopher James Vandenbussche, M.D., PH.D. is a cytopathology physician with a practice address in Baltimore, Maryland, and NPI 1811121064, issued on May 2, 2009. Check the license (Maryland D77327, as entered in NPPES) on the Maryland Board of Physicians; the Medicare figures below come from public CMS files.
- Name
- Christopher James Vandenbussche
- Credential
- M.D., PH.D.
- Primary taxonomy
- Cytopathology Physician 207ZC0500X
- License number
- D77327 MD
Self-reported in NPPES; status is on the state search - Practice location
- 1800 Orleans St, Baltimore, MD 21287
- Phone
- (410) 955-3980
- Enumerated
- May 2, 2009
- Record last updated
- Sep 11, 2017 (not updated in 9 years: call before relying on the address or phone)
- Medicaid ID
- 081535700 MD
- Medicare enrollment
- Enrolled (PECOS I20140904001149); may accept Medicare assignment
- Medical or professional school
- Georgetown University School Of Medicine, 2009
- Entity
- Type 1 · individual
8 nearest cytopathology physician records → All 15 in Maryland → Look up another NPI →
Also registered at 1800 Orleans St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kara AbarcarEmergency Medicine Physician1285195123
- Catherine Abbot, CRNPStudent in an Organized Health Care Education/Training Program1942093810
- Ahamed Akmal Abdul Rahman Lebbe, MDStudent in an Organized Health Care Education/Training Program1255208427
- Arielle AbovichStudent in an Organized Health Care Education/Training Program1972122703
- Luis Acosta, MDStudent in an Organized Health Care Education/Training Program1922859537
- Nihmotallahi Adebayo, MDStudent in an Organized Health Care Education/Training Program1033058334
Verify Christopher James Vandenbussche in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMaryland Board of Physicians
Search for license D77327Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
The practice group's MIPS final score for 2023 (Medicare payment program): 74.4 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Bills Medicare through 2 group practices
- Johns Hopkins UniversityBaltimore, MD
- Johns Hopkins UniversityMiddle River, MD
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Christopher James Vandenbussche among 15 cytopathology physician records in Maryland
Christopher James Vandenbussche, M.D., PH.D. is one of 15 cytopathology physician records with a practice address in Maryland. 33% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2009, is newer than 80% of them.
- NPI issued2009 · 80% of these records are older, 7% newer
- In a Medicare fileYes · 33% of these records are
- In the CMS Doctors and Clinicians fileYes · 33% of these records are
- Record last updated2017 · 47% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207ZC0500X and a Maryland practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Cytopathology Physician providers in Maryland
There are 15 cytopathology physician records in Maryland.
All 15 in Maryland → Every provider in Baltimore → Cytopathology Physician nationwide →
The 8 cytopathology physician records with the nearest ZIP codes
- Yurong Wheeler, MDBaltimore, MD 212871467569772
- Melissa Buick, M.D.Baltimore, MD 212291952409500
- Jean Colandrea, M.D.Baltimore, MD 212291245320407
- Curtis Ollayos, M.D.Baltimore, MD 212291114032612
- Ann Reed, M.D.Baltimore, MD 212291972617439
- Carlos Orbegoso, MDBaltimore, MD 212181508856014
- Beth Schwartz, M.D.Baltimore, MD 212041730119587
- Fowza Taqi, M.D.Towson, MD 212041588737472
Common questions
What is Christopher James Vandenbussche, M.D., PH.D.'s NPI number?
Christopher James Vandenbussche, M.D., PH.D.'s National Provider Identifier (NPI) is 1811121064, issued on May 2, 2009. An NPI identifies a provider in billing; it is not a license.
Where is Christopher James Vandenbussche, M.D., PH.D. located?
The NPPES record lists a practice address at 1800 Orleans St, Baltimore, MD, 21287. Phone: (410) 955-3980. Providers update this record themselves, so call before visiting.
How can I verify Christopher James Vandenbussche, M.D., PH.D.'s license?
NPPES lists Maryland license number D77327, as entered by the provider. Search the Maryland Board of Physicians at https://www.mbp.state.md.us/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
What is Christopher James Vandenbussche, M.D., PH.D.'s MIPS final score?
The 2023 MIPS final score is 74.4 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.